Iceland's SAGA cohort selects SMART-TRIAL Software for a Decade-Long Study on how Trauma impacts Women's Health

June 19, 2018

A large nationwide research project SAGA cohort inviting 110,000 Icelandic women to participate uses the SMART-TRIAL software.The SAGA cohort (Stress-And-Gene-Analysis) is one of the largest research projects ever undertaken to address the potential impact of trauma or severe adversities on women’s health. And the potential genetic contribution to varying health trajectories after such trauma exposure. The project Cohort Saga is undertaken by investigators at the University of Iceland in collaboration with deCODE Genetics.

The SAGA cohort study takes advantage of MEDEI’s excellent software for data management and collection.

Icelandic women participating in the SAGA cohort study answer an online questionnaire on trauma history and health and sign an informed consent for tracking of medical diagnoses and biomarkers in existing healthcare databases and biobanks during the coming decades.

"One of our most important decisions was to select a scalable data management solution for the project. Due to the sensitive topic and the large target size, we had high demands on both security and usability. We believe we made the right decision by selecting SMART-TRIAL, because it meets our requirements for both compliance and a user-friendly interface."

says Unnur A. Valdimarsdóttir, Principle Investigator and, Project Guarantor.

“MEDEI is proud to be associated with such a large and prestigious humanitarian research project, our innovative and scalable SMART-TRIAL software platform is designed for such large projects and will help Cohort Saga to simplify and better manage the on-going collection of data from this nationwide research project.”

says Jón I. Bergsteinsson, MEDEI’s vice-president of global business development.

For further information and images, please contact:Jón Ingi BergsteinssonMEDEI ApSVice President for Global Business DevelopmentTel: +45 42 70 70 03Email: